IMPROVING CARE FOR PEDIATRIC URINARY TRACT INFECTION: RELATIONSHIP BETWEEN IMPLEMENTATION OF A CLINICAL PATHWAY AND PRESCRIBING PATTERNS IN THE ED. Issue 11 (22nd October 2015)

• Record Type: Journal Article
• Authors: Caglar, Derya; Poole, Nicole; Migita, Russ; Kronman, Matthew; Zerr, Danielle; Rutman, Lori
• Is Part Of: BMJ quality & safety. Volume 24:Issue 11(2015)
• Page Start: 727
• Page End: 728
• Publication Date: 2015-10-22
• Subjects: Medical care -- Quality control -- Periodicals; Health facilities -- Risk management -- Periodicals; Medical errors -- Prevention -- Periodicals; 362.106805
• DOI: 10.1136/bmjqs-2015-IHIabstracts.12
• Languages: English
• ISSNs: 2044-5415

Abstract

Abstract : Background: Urinary tract infections (UTIs) are the most common serious bacterial infection in children; nearly 10% of girls and 2% of boys are affected during their first 8 years of life. Broad-spectrum antibiotics are popular first-line treatment agents; however, these medications can lead to resistant organisms and more severe infections over time. In July 2010, our institution implemented a clinical pathway for children presenting to the ED with UTI based on national guidelines and local consensus regarding the need for antimicrobial stewardship. A goal of the pathway was to increase narrow spectrum (cephalexin) and decrease broad spectrum (cefixime) antibiotic use for children with uncomplicated UTI presenting to the ED. Objectives: To determine the impact of a UTI clinical pathway on provider antibiotic prescribing patterns. Methods: We used statistical process control (p-charts) to analyze the percentage of patients receiving each antibiotic over time. Data were analyzed over a 6-year period; 1.5 years before and 4.5 years after pathway implementation. Results: 2292 patients were included. The percentage of patients receiving targeted narrow spectrum antibiotics increased from an average of 19% to 73% (figure 1). There was a concomitant decrease in the percentage of patients receiving broad-spectrum antibiotics (cefixime) from 46% to 3% (figure 2). Special cause variation was noted twice during the study period; immediately following pathway implementation and again 6 months later when the pathway was revised to increase provider education regarding appropriate antibiotic use. Conclusions: Implementation of clinical pathways for UTI can result in sustained improvements in antimicrobial stewardship among children seen in ED settings.Figure 1 Figure 2